Off-label use of prescription drugs

American Family Physician

Volumn 68, Issue 3, 2003, Pages 425-427

  Nightingale, Stuart L ^a  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; SEROTONIN UPTAKE INHIBITOR;

DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG INDUSTRY; DRUG LABELING; DRUG LEGISLATION; DRUG MARKETING; DRUG SAFETY; DRUG USE; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH CARE POLICY; HUMAN; PRACTICE GUIDELINE; PRESCRIPTION; REIMBURSEMENT;

DRUG APPROVAL; DRUG LABELING; DRUG UTILIZATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PHARMACEUTICAL PREPARATIONS; PRESCRIPTIONS, DRUG; SAFETY; SEROTONIN UPTAKE INHIBITORS;

EID: 0042063623     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (12)

1. Stone KJ, Viera AJ, Parman CL. Off-label applications for SSRIs. Am Fam Physician 2003;68:497-504.
2. Nightingale SL. Use of drugs for unlabeled indications. Am Fam Physician 1986;34:269.
3. Nightingale SL. Unlabeled uses of approved drugs. Drug Inf J 1992;26(2):141-7.
4. Jagger SF. Prescription drugs: implications of drug labeling and off-label use. Statement before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U.S. House of Representatives. Washington, D.C.: General Accounting Office, 1996.
5. Cranston JW, Williams MA, Nielsen NH, Bezman RJ, Bresolin LB. Council on Scientific Affairs, America Medical Association. Report of the Council on Scientific Affairs: unlabeled indications of Food and Drug Administration-approved drugs. Drug Inf J 1998;32:1049-61.
6. Best pharmaceuticals for children act: Public law 107-109 (S. 1789). Retrieved July 14, 2003, from: www.fda.govlopacom/laws/pharmkids/contents.html.
7. Use of approved drugs for unlabeled indications. FDA Drug Bull 1982;12(1):4-5.
8. Labeling for prescription drugs used in man; proposed format for prescription-drug advertisements. Federal Register 1975;40(67):15392-9.
9. Patient access to treatments prescribed by their physicians. American Medical Association Policy H120.988. AMA Policy Database. Retrieved July 14, 2003, from: www.ama-assn.org/apps/pf_online/ pf_online.
10. American Academy of Pediatrics, Committee on Drugs. Use of drugs not described in the package insert (off-label uses). Pediatrics 2002;110:181-3.
11. United States Pharmacopeial Convention. USP DI: drug information for the health care professional. 23rd ed. Greenwood Village, Colo.: Thomson/MICROMEDEX, 2003.
12. McEvoy GK. AHFS drug information 2003. Bethesda, Md.: American Society of Health-Systems Pharmacists, 2003.